Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 12, December, p. 1701–1709

doi: 10.17219/acem/75869

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

The relationship between IFN-γ and TNF-α gene polymorphisms and brucellosis: A meta-analysis

Ebrahim Eskandari-Nasab1,A,B,C,E, Mehdi Moghadampour2,A,B,C,D,E,F

1 Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Iran

2 Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Iran

Abstract

Background. Brucellosis is an infectious disease and one of the major public health problems worldwide. Several current studies have provided data that polymorphisms in the interferon-gamma gene (IFN-γ) and tumor necrosis factor-alpha gene (TNF-α) are related to brucellosis.
Objectives. The aim of this study was to investigate the relationship between IFN-γ +874 A/T, IFN-γ UTR5644 A/T, TNF-α −308 G/A, and TNF-α −238 G/A single nucleotide polymorphisms (SNPs) and brucellosis risk by meta-analysis.
Material and Methods. We performed a comprehensive search of the PubMed, MEDLINE, EMBASE, Web of Science, and Elsevier Science Direct databases. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were used to measure the strength of association between IFN-γ and TNF-α polymorphisms and brucellosis risk.
Results. A total of 17 studies including 1,904 cases and 2,233 controls fulfilled the inclusion criteria. Our pooled analysis demonstrated that the IFN-γ +874 AT vs AA genotype in a codominant model may confer an increased risk of brucellosis in the overall population (p = 0.001; OR = 0.51). Regarding TNF-α −308 G/A, our pooled analysis revealed that the AA vs GG + GA (recessive) genotype increased the risk of brucellosis (p = 0.02; OR = 2.00).
Conclusion. In summary, our pooled analysis suggested that the IFN-γ +874 AT vs AA as well as the TNF-α −308 AA vs GG + GA genotypes demonstrated a trend for the association with a higher risk of brucellosis.

Key words

IFN-γ, TNF-α, gene polymorphism, brucellosis, meta-analysis

References (22)

  1. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005;352:2325–2336.
  2. Eskandari-Nasab E, Moghadampour M, Hasani SS, et al. Relationship between gamma-interferon gene polymorphisms and susceptibility to brucellosis infection. Microbiol Immunol. 2013;57:785–791.
  3. Pappas G, Memish ZA. Brucellosis in the middle East: A persistent medical, socioeconomic and political issue. J Chemother. 2007;19:243–248.
  4. Moghadampour M, Eskandari-Nasab E, Shabani F. Relationship between CD14-159C/T gene polymorphism and acute brucellosis risk. Asian Pac J Trop Med. 2016;9:247–251.
  5. Eskandari-Nasab E, Moghadampour M, Najibi H, Hadadi-Fishani M. Investigation of CTLA-4 and CD86 gene polymorphisms in Iranian patients with brucellosis infection. Microbiol Immunol. 2014;58:135–141.
  6. Akhvlediani T, Clark DV, Chubabria G, Zenaishvili O, Hepburn MJ. The changing pattern of human brucellosis: Clinical manifestations, epidemiology and treatment outcomes over three decades in Georgia. BMC Infect Dis. 2010;10:346.
  7. Moreno E. Retrospective and prospective perspectives on zoonotic brucellosis. Front Microbiol. 2014;5:213.
  8. Christopher S, Umapathy BL, Ravikumar KL. Brucellosis: Review on the recent trends in pathogenicity and laboratory diagnosis. J Lab Physicians. 2010;2:55–60.
  9. Rasouli M, Kiany S. Association of interferon-gamma and interleukin-4 gene polymorphisms with susceptibility to brucellosis in Iranian patients. Cytokine. 2007;38:49–53.
  10. Eskandari-Nasab E, Moghadampour M, Asadi-Saghandi A, Kharazi-Nejad E, Rezaeifar A, Pourmasoumi H. Levels of interleukin-(IL)-12p40 are markedly increased in brucellosis among patients with specific IL-12B genotypes. Scand J Immunol. 2013;78:85–91.
  11. Eskandari-Nasab E, Moghadampour M, Sepanj-Nia A. TNF-alpha −238, −308, −863 polymorphisms and brucellosis infection. Hum Immunol. 2016;77:121–125.
  12. Bravo MJ, de Dios Colmenero J, Alonso A, Caballero A. Polymorphisms of the interferon gamma and interleukin 10 genes in human brucellosis. Eur J Immunogenet. 2003;30:433–435.
  13. Karaoglan I, Pehlivan S, Namiduru M, et al. TNF-alpha, TGF-beta, IL-10, IL-6, and IFN-gamma gene polymorphisms as risk factors for brucellosis. New Microbiol. 2009;32:173–178.
  14. Caballero A, Bravo MJ, Nieto A, Colmenero JD, Alonso A, Martin J. TNFA promoter polymorphism and susceptibility to brucellosis. Clin Exp Immunol. 2000;121:480–483.
  15. Davoudi S, Amirzargar AA, Hajiabdolbaghi M, et al. Th-1 cytokines gene polymorphism in human brucellosis. Int J Immunogenet. 2006;33:355–359.
  16. Budak F, Goral G, Heper Y, et al. IL-10 and IL-6 gene polymorphisms as potential host susceptibility factors in brucellosis. Cytokine. 2007;38:32–36.
  17. Hedayatizadeh-Omran A, Rafiei A, Hajilooi M, Haghshenas M. Interferon-gamma low producer genotype +5644 over presented in patients with focal brucellosis. Pak J Biol Sci. 2010;13:1036–1041.
  18. Chen X, Xu J, Chen Z, et al. Interferon-gamma +874A/T and interleukin-4 intron3 VNTR gene polymorphisms in Chinese patients with idiopathic thrombocytopenic purpura. Eur J Haematol. 2007;79:191–197.
  19. Ansari A, Hasan Z, Dawood G, Hussain R. Differential combination of cytokine and interferon-gamma +874 T/A polymorphisms determines disease severity in pulmonary tuberculosis. PLoS One. 2011;6:e27848.
  20. Zhan Y, Liu Z, Cheers C. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun. 1996;64:2782–2786.
  21. Feldman KE, Loriaux PM, Saito M, et al. Ex vivo innate immune cytokine signature of enhanced risk of relapsing brucellosis. PLoS Negl Trop Dis. 2013;7:e2424.
  22. Reza JS, Alireza R, Mostafa A, Alireza K, Mehrdad H. Association of tumor necrosis factor-alpha-308 (G-->A) polymorphism and susceptibility to brucellosis. J Microbiol Immunol Infect. 2009;42:22–26.